15325 Effects of guselkumab on musculoskeletal features in patients with active psoriatic arthritis by baseline skin disease: Results from the phase 3 DISCOVER-1 and DISCOVER-2 studies

Alice B Gottlieb

https://doi.org/10.1016/j.jaad.2020.06.232

Copy DOI

Journal: Journal of the American Academy of Dermatology	Publication Date: Nov 28, 2020
Citations: 1

Abstract

Objective: To evaluate the impact of guselkumab (GUS) on musculoskeletal features of PsA by baseline skin disease.

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author